Evaluation of the SpinCare™ System in the Treatment of Partial Thickness Burns

Inclusion Criteria: * Patients ≥ 18 years old at enrolment. Both genders. * The patient has partial thickness burn wounds (second degree superficial to intermediate) of up to 10% TBSA; of which the target wound for treatment is of up to 5% TBSA or up to 300cm2. * Presenting at the emergency room within the first 24-48 hours post-injury. * Patient's wound is defined as a partial thickness burn for conservative treatment (superficial to intermediate second degree). * Patient underwent cleansing/debridement of initial burn before applying the dressing * The patient is able and willing to comply with study procedures and give written informed consent prior to enrollment in the study Exclusion Criteria: * Any known or suspected systemic infection * Any known sensitivity to components/products used in this study * Any active, uncontrolled, progressive or untreated malignancy * Use of penicillamine, corticosteroid or immunosuppressive medication within two months prior to enrollment or who is likely to be prescribed these medications or any other medications known to adversely affect wound healing during study participation * Major uncontrolled systemic disorders such as hepatic, renal, neurologic, or endocrinologic disorders * Major dermatological disorders such as: psoriasis, pemphigus, Steven Johnson, etc. * Patients with burns larger than 10% TBSA * Patients with burns up to 10% TBSA but no target wound of up to 5% TBSA or up to 300cm2 * Patients suffering from electrical or chemical burns. * Patients suffering from frostbites. * Patients suffering from burn wounds that are third degree or full thickness. * Patients suffering from burn wounds in the head, neck or genital areas * Female patients who are pregnant or nursing * Psychiatric patient. * Soldiers * Participation in another clinical trial within 30 days prior to the Screening Visit